iXensor has recently announced that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark. MobiHealthNews and other media covered the end-to-end fully digitalised rapid screening solution features: “It comprises a palm-sized analyser, a digital health pass app, an admin app and a HIPAA-grade health management web portal. Its diagnostic solution…
iXensor, the pioneer of mobile health, announces today that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark. iXensor provides the end-to-end fully digitalized solution to prevent further outbreaks. iXensor’s PixoTest® solution comprises a palm-sized analyzer that reads test results accurately, a digital health pass App, an Admin…
TAIPEI, TAIWAN; – May 20, 2021 – iXensor Co., Ltd. (6734.TWO) Dr. Carson Chen, CEO of iXensor, today participated in Johnson & Johnson Innovation’s webinar “The Future of Pandemic Prevention: Innovation Ecosystem Collaboration” together with renowned experts including Rick Bright (SVP Pandemic Prevention and Response at Rockefeller Foundation, former director…
Med-Tech Innovation News talks about how iXensor can bring smartphone technology to aid COVID-19 testing. Bringing the end-to-end digital COVID-19 screening solution PixoTest® POCT COVID-19 Antigen Testing, iXensor is ready to help organizations preventing outbreaks. “PixoTest provides computer analyzed COVID-19 test results, lowering the risks caused by misinterpretation of human eyes. The…
iXensor, the pioneer of mobile health, is set to launch its end-to-end digital COVID-19 rapid antigen test solution that digitizes the entire user journey from screening, reporting to access control to combat outbreaks. The clinical performance evaluation has demonstrated superior accuracy of the PixoTest® POCT COVID-19 Antigen Test. The test…
While the current COVID-19 pandemic keeps impacting us globally, this will hardly have been the last pandemic of our times. What can we do to be better prepared or even prevent it from happening, though? Join our CEO, Dr. Carson Chen, as he discusses this timely topic together with other…
Rising burden of non-communicable diseases Similar to other developing countries, diabetes and other non-communicable diseases (NCDs) have become a threat to Kenya a decade ago. Particularly, diabetes often results in life-long, irreversible complications that are usually very costly to treat. It was reported that the prevalence of diabetes in Kenya…
Business Challenge In the face of COVID-19, health care systems worldwide have been prompted to spare non-critical hospital visits among chronic disease patients. As a result, chronic disease patients face a very unique challenge, as their health condition demands long-term monitoring, active alerting and near-by consultancy with comprehensive records of…
While most major economies continue to strive against rising infections and deaths caused by the novel coronavirus, Taiwan has set itself up for an economic revival due to its successful pandemic control measures. The CEO of iXensor,Carson Chen, invited by the Society for Promotion of East West Knowledge Transfer, gave…
iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its upcoming product launch in January 2021. The PixoTest® COVID-19 Antigen Test, together with the PixoTest® POCT Analyzer, can yield positive results objectively in as short as 5 minutes through computer-aided analysis, minimizing the chances of…
